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Abstract
Background: Intracerebral hemorrhage is a subtype of stroke that has a poor prognosis without an adequate
therapy. Recently, the use of anesthetics such as isoflurane has been shown to be protective after cerebral ischemia.
However, the potential therapeutic effect of isoflurane after intracerebral hemorrhage (ICH) has not been fully
explored.
Results: In this study, male Sprague–Dawley rats (SD) were subjected to ICH and randomized into controls and
1.2% or 1.5% isoflurane posttreatment groups. Brain water content, neurological outcomes and matrix
metalloproteinase-2 and -9 (MMP2-MMP9) plasma levels were quantified at 24 hours. Isoflurane treatment did not
reduce brain edema compared with controls in any of the applied isoflurane concentrations. Moreover, consistent
with this lack of effect on brain edema, isoflurane posttreatment did not affect neurological outcomes in any of the
tests used. Plasma MMP levels did not change.
Conclusion: Our data suggested that there is no neuroprotection after isoflurane posttreatment in a rat model of ICH.
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Background
Intracerebral hemorrhage (ICH) is a subtype of stroke
with the highest mortality of all stroke subtypes. ICH is
characterized by extravasation of blood into the brain par-
enchyma with hematoma formation and concomitant
edema and secondary brain damage [1,2]. The prognosis
after ICH is poor and no widely effective treatments exist.
Recently, two endogenous neuroprotective mecha-
nisms have been shown to be broadly effective after is-
chemic stroke: ischemic preconditioning and ischemic
postconditioning [3,4]. These two strategies are thought
to recruit natural adaptive responses that brain and
other organs utilize to protect themselves from various
insults. What is interesting is that many of the condi-
tioning pathways are highly conserved, i.e. protection
can be induced by a wide range of sublethal triggers
[5,6]. Recently, isoflurane has been shown to be highly
effective conditioning inducer in various animal models
of cerebral injury. This may be translationally relevant
since isoflurane can be easily applied in a clinical setting.
In particular, isoflurane postconditioning had been
widely demonstrated to be protective after the ischemia
[7]. Here, we ask whether isoflurane may also have some
neuroprotective effect when administrated after ICH.
Methods
Rat intracerebral hemorrhage model
All experiments were performed following protocols ap-
proved by Massachusetts General Hospital Institutional
Animal Care and Use Committee in accordance with the
National Institute of Health Guide for the Care and Use
of Laboratory Animals. All procedures were performed
in a blinded and randomized fashion. ICH was induced
by collagenase injections. Male Sprague–Dawley rats
(7 rats for each group) (Charles River Laboratories,
Wilmington, MA) were anesthetized with isoflurane
(1.2%) in 30%/70% oxygen/nitrous oxide. A catheter in
the tail artery was used for measuring blood pressure,
pH, PaO2, and PaCO2. Using a stereotactic frame, 1 μL
of saline containing 0.5 U collagenase VII-S (Sigma) was
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the right striatum (from bregma: 1.2 mm anterior,
3.5 mm lateral, 5.3 mm depth). 10 minutes after the col-
lagenase injection, rats were randomized into isoflurane
(1.2% and 1.5% isoflurane through a face mask for
1 hour) versus control groups. All endpoints were
assessed in a blinded manner.
Measurement of brain edema
A standard wet–dry method was used for the measure-
ment of total brain water content as an indicator of
edema. At 24 hours after ICH, rats were euthanized and
brains were removed immediately, without fixation. A
single 4-mm section was cut centered around the
hematoma, and edema was calculated as: [(wet weight −
dry weight)/wet weight] ×100%.
Gelatin zymography
Matrix metalloproteinase-2 and −9 levels in plasma were
assessed with standard gelatin zymography. EDTA blood
samples were immediately centrifuged at 10000 rpm for
10 minutes to obtain supernatants. Equal amounts of
prepared protein samples were loaded and separated.
After electrophoretic separation, the gel was renaturated
and then incubated with developing buffer at 37°C for
20 hours. After developing, the gel was stained and
then destained appropriately. Proteolytic bands in the
zymography were quantified via densitometry.
Neurological tests
The rats were assessed blindly at 24 hours using 3 tests:
forelimb placement, body swing test, and a 5-point
neuroscore scale. For the forelimb-placing test, animals
were held close to a tabletop and scored for the ability
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Figure 1 Quantization of hemorrhagic edema after 24 hours. Brain water content in the ipsilateral hemisphere was significantly greater
than the contralateral hemisphere in both control and isoflurane groups *P<0.05. However, ipsilateral water content was not affected by 1.2%
and1.5% isoflurane. All values depicted as mean±S.D.
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Figure 2 Neurological outcomes were quantified at 24 hours in 1.2% and 1.5% isoflurane group compared with untreated controls.
There were statistically significant differences between any of the treatment groups for (A) the forelimb placement test, (B) body swing test,
and (C) neuroscore. All values depicted as mean±S.D.
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whisker, visual, tactile, or proprioceptive stimulation. For
the body swing test, animals were held approximately
one inch from the base of their tails and elevated to an
inch above a surface of a table. A swing was recorded
whenever the rat moved its head out of the vertical axis
to either side by more than 10° from vertical and then
returned to the vertical position. Thirty total swings
were counted per animal. Neuroscores were graded as
0 =no apparent deficit; 1 = slight deficit; 2 =circling;
3 =heavy circling or no movement at all; or 4 =death.
Statistic analysis
Values are expressed as means ± S.D. Statistical analysis
was performed with ANOVA, followed by Newman-Keuel’s
test. Neurological outcomes (forelimb placement test, swing
test, neuroscore) were analyzed using the nonparametric
Kruskal-Wallis test. Statistical significance was accepted at
the 95% confidence level (p < 0.05).
ARRIVE (animal research: reporting in vivo experiments)
guidelines
All experiments were performed following protocols ap-
proved by Massachusetts General Hospital Institutional
Animal Care and Use Committee in accordance with the
National Institute of Health Guide for the Care and Use
of Laboratory Animals. All studies herein, including ex-
perimental design, animal care and use, randomization,
blinding, statistical powering and analyses, inclusion/ex-
clusion criteria, outcomes etc. are explicitly defined fol-
lowing ARRIVE guidelines.
Results
As expected, this standard model of collagenase injections
resulted in reproducible intrastriatal hematomas. There
were no statistically significant differences in hematoma
volumes in controls vs 1.2% or 1.5% isoflurane treatment
groups. Accordingly, brain edema developed in all groups
- brain water content in the ipsilateral hemisphere was
significantly greater than the contralateral hemisphere
(control group: ipsilateral, 81.5%±0.8% versus contrala-
teral, 78.9%±0.4% P<0.05; 1.2% isoflurane group: ipsila-
teral, 81.6%±0.2% versus contralateral, 78.8%±0.6%
P<0.05; 1.5% isoflurane group: ipsilateral, 81.3%±0.4%
versus contralateral, 78.7%±0.3% P<0.05). However,
isoflurane treatment did not reduce brain edema com-
pared with controls in any of the applied isoflurane con-
centrations (P=0.653) (Figure 1).
Consistent with this lack of effect on brain edema,
isoflurane posttreatment did not affect neurological out-
comes in any of the tests used (Figure 2A,B,C). In the
forelimb placement test, 1.2% and 1.5% isoflurane had
no effect on the outcomes (control ipsilateral group,
5.43 ±1.8; 1.2% isoflurane ipsilateral group, 6.33 ±1.15;
Table 1 Physiological parameters
Controls Isof 1.2% Isof 1.5%
MABP (mmHg)
before ICH 105.80±5.9 104.4±6.9 99.20±5.3
30′ after ICH 106.8±1.9 107.4±5.4 96.8±8.17
1 h after ICH 106.06±3.9 100.8±5.5 89.4±6.07
pH
before ICH 7.47±0.001 7.44±0.017 7.44±0.034
30′ after ICH 7.41±0.020 7.42±0.046 7.42±0.017
1 h after ICH 7.41±0.017 7.41±0.021 7.39±0.036
pO2
before ICH 159.80±7.26 190.60±46.71 167.8±17.4
30′ after ICH 158.4±23.04 180.2±21.79 155.6±36.88
1 h after ICH 159.60±15.34 189.80±8.44 159.00±7.84
pCO2
before ICH 34.1±2.42 39.8±3.90 33.5±2.69
30′ after ICH 41.98±1.56 41.9±4.62 37.0±3.48
1 h after ICH 41.5±2.11 43.2±3.80 38.16±6.07
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Figure 3 Zymographic detection of MMP-2 and MMP-9 in
plasma control and isoflurane groups. (A) Representative gelatin
zymography. (B) Densitometric quantization (mean ± S.D.) detected
no differences in MMP-2 and MMP-9 plasma levels between the
1.2% and 1.5% isofurane groups vs the control group.
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Both 1.2% and 1.5% isoflurane posttreatment also had
no detectable effect on the body-swing test (control
group, 22.9± 7.2; 1.2% isoflurane group, 26.33 ±3.2;
1.5% isoflurane group, 20.4 ±10.6. P =0.368). Finally,
isoflurane did not affect neuroscore outcomes (control
ipsilateral group, 1.76± 1.0; 1.2% isoflurane ipsilateral
group, 1.5±0.7; 1.5% isoflurane ipsilateral group,
1.8± 0.8. P =0.773) or rates of mortality.
Isoflurane can lower blood pressure. In this study,
blood pressure in the 1.5% isoflurane group was signifi-
cantly lower than the 1.2% isoflurane and control
groups. All other physiological parameters were within
the normal range in all groups from the beginning of
surgery until 1 hour after ICH induction (corresponding
to the end of isoflurane treatments) (Table 1).
Gel zymography from plasma of rats post-treated
with 1.2 or 1.5% isoflurane did not reveal any changes
in matrix metalloproteinases MMP-2 or MMP-9
levels compared with control rats at 24 hrs after ICH
(MMP9: control group, 100% ±15.5; 1.2% isoflurane
group, 106.86 ± 28.2; 1.5% isoflurane group, 92.14±15.1.
P =0.539. MMP2: control group, 100%± 15.1; 1.2%
isoflurane group, 91.94 ±12.3; 1.5% isoflurane group,
103.40 ±7.6. P =0.223) (Figure 3A,B).
Discussion
In the last few years, many advances have been obtained
in term of dissecting the signaling pathways activated by
endogenous neuroprotective mechanisms after an ische-
mic insult [8]. Interestingly, it has been recently reported
that ischemic preconditioning, a sublethal ischemic epi-
sode applied before a longer harmful ischemia [9], and
ischemic postconditioning, a sublethal ischemia subse-
quent to a prolonged harmful ischemic episode, are both
able to produce remarkable neuroprotection in various
models of stroke and neuronal injury. However,
preconditioning or postconditioning with an ischemic
stimulus, although useful for proof-of-concept and
dissecting molecular mechanisms, may be difficult to
apply in a clinical setting. More recently, it has been sug-
gested that conditioning may also be stimulated with
various pharmacologic approaches. Emerging studies
now suggest that the widely used anesthetic isoflurane
can induce postconditioning and protect heart and brain
against ischemia [10]. However, the potential therapeutic
effect of isoflurane has not been fully explored after in-
tracerebral hemorrhage (ICH). Here, we ask whether
isoflurane, as showed during ischemic postconditioning,
may also have some neuroprotective effect when admin-
istrated after ICH.
Two concentrations of isoflurane were tested in a
well-established rat model of collagenase-induced ICH.
Our data demonstrated that isoflurane posttreatment
did not affect edema. Since neurovascular damage after
ICH is closely related to MMP activation [11,12], we also
assessed potential MMP biomarker levels in plasma.
Once again, no effects of isoflurane were detected.
Finally, consistent with the lack of morphological or bio-
chemical effects, there were no differences in a wide bat-
tery of neurological tests at 24 hrs post-ICH. The
observed lack of beneficial effects following isoflurane
treatment in the present study may be due to the lower
doses tested here. Blood pressure effects prevented us
from assessing higher isoflurane concentrations. How-
ever, we cannot unequivocally exclude the possibility
that higher doses may have had beneficial effects in this
ICH model system.
In contrast to our negative results, Khatibi et al. [13]
recently suggested that 1.5% isoflurane posttreatment
significantly reduced peri-hematoma edema, ameliorated
apoptotic cell death and rescued neurologic function in
a different model of ICH. These different results could
be related to a species difference (mice vs rats) or to the
different methods used to produce ICH. In the previous
Kathibi et al. study, ICH was induced by infusing autolo-
gous blood into the striatum of mice. In the present
study, collagenase injections were used to produce cere-
brovascular rupture and hemorrhage in rat brains. There
are no perfect animal models of ICH. But the potential
advantage of the collagenase model is that it replicates
the primary vascular trauma and rupture that is present
in human ICH [14]. However, a potential drawback is
that compared to the blood infusion model, the collage-
nase approach may be associated with altered inflamma-
tory responses [15].
Conclusions
In conclusion, our study was unable to show a protective
effect of isoflurane posttreatment in a rat model of
collagenase-induced ICH. This negative study may be im-
portant because it suggests that, compared to cerebral is-
chemia, the beneficial actions of isoflurane posttreatment
may not be as robust for other subtypes of stroke. Further
studies are required to carefully test isoflurane in a wider
spectrum of ICH animal models before any translation
into clinical applications can be contemplated.
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